Elimination of Proliferating Cells From CNS Grafts Using a Ki67 Promoter-Driven Thymidine Kinase
Molecular Therapy - Methods and Clinical Development - United States
doi 10.1038/mtm.2016.69
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2016
Authors
Publisher
Elsevier BV